Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Year-over-year net income growth rate
Percentile
P34
Within normal range
vs 2Y Ago
-0.1x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -22.98% |
| Q3 2025 | 3.38% |
| Q2 2025 | 108.83% |
| Q1 2025 | 196.07% |
| Q4 2024 | 29.98% |
| Q3 2024 | -224.80% |
| Q2 2024 | 77.93% |
| Q1 2024 | -170.15% |
| Q4 2023 | 282.15% |
| Q3 2023 | -192.54% |
| Q2 2023 | 222.02% |
| Q1 2023 | -375.05% |
| Q4 2022 | -98.01% |
| Q3 2022 | 1221.53% |
| Q2 2022 | 20.74% |
| Q1 2022 | 30.61% |
| Q4 2021 | -18.95% |
| Q3 2021 | 26.51% |
| Q2 2021 | 16.01% |
| Q1 2021 | 7.78% |
| Q4 2020 | -22.40% |
| Q3 2020 | -16.99% |
| Q2 2020 | -41.83% |
| Q1 2020 | 16.91% |
| Q4 2019 | -17.51% |
| Q3 2019 | 27.25% |
| Q2 2019 | 43.50% |
| Q1 2019 | -54.58% |
| Q4 2018 | -74.47% |
| Q3 2018 | -20.47% |
| Q2 2018 | -26.76% |
| Q1 2018 | 51.13% |
| Q4 2017 | -104.01% |
| Q3 2017 | -43.08% |
| Q2 2017 | -126.74% |
| Q1 2017 | 0.00% |